• NEWS

    Read the Latest News From NewBridge 

  • 1
Press Release

NewBridge Pharmaceuticals at WCO-IOF-ESCEO Paris 2019

NewBridge Pharmaceuticals -2018 winner of the Most Innovative Pharmaceutics Commercialisation Partner MENA award
NewBridge Pharmaceuticals at EASL 2019

Joe Henein, the President & CEO of NewBridge Pharmaceuticals, Sherif Hamdy Franchise Head Metabolic Care and Lina Sabbagh Commercial Lead CNS Lebanon attended the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO) in Paris from April 4th till 7th, 2019 along with the Abiogen team.

NewBridge Pharmaceuticals -2018 winner of the Most Innovative Pharmaceutics Commercialisation Partner MENA award
NewBridge Pharmaceuticals at EASL 2019